The objective of this study is to determine the product feasibility of the investigational contact lens (Test) when compared to the currently marketed Acuvue Oasys contact lens (Control) and the Air Optix Aqua contact lens (Control) when worn by adapted wearers of soft contact lenses.

After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.

Active Comparator: Acuvue Oasys Contact Lens

Johnson & Johnson Lens

Device: Acuvue Oasys Contact Lens

After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.

Active Comparator: Air Optix Aqua

Ciba Vision

Device: Air Optix Aqua

After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.

Eligibility

Ages Eligible for Study:

18 Years and older (Adult, Senior)

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Participants must have clear central corneas and be free of any anterior segment disorders.

Participants must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.

Participants must be myopic and require lens correction from -0.75 D to - 4.75D in each eye.

Exclusion Criteria:

Participants who have worn gas permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last three months.

Participants with any systemic disease affecting ocular health.

Participants using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.

Participants with an active ocular disease or are using any ocular medication.

Participants who have had any corneal surgery (eg, refractive surgery).

Participants who are allergic to any component in the study care products.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01131130